000 | 01928 a2200529 4500 | ||
---|---|---|---|
005 | 20250514063824.0 | ||
264 | 0 | _c20030617 | |
008 | 200306s 0 0 eng d | ||
022 | _a0945-6317 | ||
024 | 7 |
_a10.1007/s00428-003-0775-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBuzello, Moriz | |
245 | 0 | 0 |
_aMyocyte loss in early left ventricular hypertrophy of experimental renovascular hypertension. _h[electronic resource] |
260 |
_bVirchows Archiv : an international journal of pathology _cApr 2003 |
||
300 |
_a364-71 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
650 | 0 | 4 | _aApoptosis |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 | _aCell Count |
650 | 0 | 4 |
_aDihydralazine _xtherapeutic use |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aHeart Ventricles _xdrug effects |
650 | 0 | 4 |
_aHypertension, Renovascular _xdrug therapy |
650 | 0 | 4 |
_aHypertrophy, Left Ventricular _xdrug therapy |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aIn Situ Nick-End Labeling |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
650 | 0 | 4 | _aOrgan Size |
650 | 0 | 4 |
_aProliferating Cell Nuclear Antigen _xmetabolism |
650 | 0 | 4 |
_aProto-Oncogene Proteins _xmetabolism |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _abcl-2-Associated X Protein |
700 | 1 | _aBoehm, Christoph | |
700 | 1 | _aOrth, Stephan | |
700 | 1 | _aFischer, Bernhard | |
700 | 1 | _aEhmke, Heimo | |
700 | 1 | _aRitz, Eberhard | |
700 | 1 | _aMall, Gerhard | |
700 | 1 | _aAmann, Kerstin | |
773 | 0 |
_tVirchows Archiv : an international journal of pathology _gvol. 442 _gno. 4 _gp. 364-71 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00428-003-0775-5 _zAvailable from publisher's website |
999 |
_c12476883 _d12476883 |